Masimo (MASI) Non Operating Income (2009 - 2026)
Masimo's (MASI) quarterly Non Operating Income came in at -$6.1 million in Q2 2026, up 36.46% year-on-year from -$4.5 million in Q2 2025, and up 38.38% quarter-over-quarter from -$9.9 million in Q1 2026.
Masimo (MASI) Non Operating Income (2009 - 2026) Analysis & Trends
Masimo's Non Operating Income history runs 18 years deep, the most recent figure standing at -$6.1 million for Q2 2026.
- On a quarterly basis, Non Operating Income rose 36.46% year-over-year to -$6.1 million in Q2 2026; TTM through Apr 2026 was -$33.8 million, a 13.78% increase from a year earlier, with the FY2026 full-year figure at -$37.4 million, up 9.22% from the prior year.
- Non Operating Income climbed to -$6.1 million in Q2 2026 per MASI's latest filing, from -$9.9 million in the prior quarter.
- Across five years, Non Operating Income topped out at $4.5 million in Q3 2022 and bottomed at -$25.5 million in Q4 2023.
- The 5-year median for Non Operating Income is -$9.3 million (2024), against an average of -$9.0 million.
- Across the five-year window, Non Operating Income soared 4400.0% in 2022 and slumped 1866.67% in 2023, its largest moves.
- Year by year, Non Operating Income stood at -$17.6 million in 2022, then sank by 44.89% to -$25.5 million in 2023, then surged by 62.75% to -$9.5 million in 2024, then increased by 8.42% to -$8.7 million in 2025, then advanced by 29.89% to -$6.1 million in 2026.
- Per Business Quant, the three latest MASI Non Operating Income figures stand at -$6.1 million (Q2 2026), -$9.9 million (Q1 2026), and -$8.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | -6.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -6.10 Mn |
| Jan 3, 2026 | -9.90 Mn |
| Sep 27, 2025 | -8.70 Mn |
| Jun 28, 2025 | -9.10 Mn |
| Mar 29, 2025 | -9.60 Mn |
| Dec 28, 2024 | -9.50 Mn |
| Sep 28, 2024 | -9.00 Mn |
| Jun 29, 2024 | -11.10 Mn |
| Mar 30, 2024 | -11.60 Mn |
| Dec 30, 2023 | -25.50 Mn |
| Sep 30, 2023 | -11.20 Mn |
| Jul 1, 2023 | -4.50 Mn |
| Apr 1, 2023 | -11.80 Mn |
| Dec 31, 2022 | -17.60 Mn |
| Oct 1, 2022 | -2.80 Mn |
| Jul 2, 2022 | 4.50 Mn |
| Apr 2, 2022 | -600,000.00 |
| Jan 1, 2022 | -7.51 Mn |
| Jul 3, 2021 | 100,000.00 |
| Apr 3, 2021 | -737,000.00 |